001060.KS
JW Pharmaceutical Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 27,150.00
−2.16%Leverage
- Debt / equity
- 0.18x
- Net debt / equity
- 0.07x
- Debt / assets
- 0.11x
- Debt / EBITDA
- 0.57x
- Net debt / EBITDA
- 0.22x
Liquidity & coverage
- Current ratio
- 1.56x
- Quick ratio
- 1.06x
- Cash ratio
- 0.27x
- Interest coverage
- 14.93x
- EBITDA / interest
- 16.41x
- Working capital
- KRW 123.9B
Cash & dividend
- FCF / debt
- 1.59x
- Cash flow / debt
- 1.87x
- Dividend per share
- KRW 650
- Dividend yield
- 2.4%
- Dividend growth 1y
- +44.4%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026